This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Search for:
Search for:
News
Clinical
Allergy
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Reports
Country profiles
Clinical Excellence
Cardiology
Respiratory
Archive Issues
2021
2020
2019
2018
2017
2016
Sponsored
Newsletter
Hospital Pharmacy Europe
Allergy
Three in 10 drug-related deaths in acute care due to omitted medicines, research reveals
Read more
Accuracy in predicting patient outcomes in milk oral immunotherapy
Read more
Towards a treatment for gluten intolerance
Read more
A hope for fish allergy sufferers?
Read more
New drug could reduce risk of allergic reaction to peanuts in children and adolescents
Read more
Results of landmark PALISADE trial published in New England Journal of Medicine
Read more
New EpiPen junior validation process mandated following ‘critical’ shortages in UK
Read more
NICE issues draft guidance not recommending dupilumab
Read more
Omalizumab recommended in global chronic urticaria guideline
Read more
Peanut allergy drug passes clinical trial
Read more
Guideline for the management of nut allergy helps to define diagnostic pathways, including the role of specific IgE testing
Read more
Reslizumab recommended by NICE
Read more
Marketing authorisation for dupilumab in moderate to severe atopic dermatitis recommended
Read more
Candidate metabolomic network for bladder cancer diagnostics
Read more
New guidance on diagnosis and management of allergic and non-allergic rhinitis published
Read more
Page 7 of 8
« First
«
...
4
5
6
7
8
»
Popular articles
Emergency medicine staffing crisis imminent unless Government acts, RCEM warns
30 May, 2023
Machine learning identifies molecule effective against organism causing nosocomial infections
30 May, 2023
Review finds plant-based diets reduce plasma lipid levels
30 May, 2023